Phenotypic effects of HPV-16 E2 protein expression in human keratinocytes

Virology

Volumn 401, Issue 2, 2010, Pages 314-321

  Burns, Julie E ^a,b   Walker, Hannah F ^a   Schmitz, Christian ^a,c   Maitland, Norman J ^a  

^a UNIVERSITY OF YORK   (United Kingdom)

^b ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

^c CliMECS GmbH IZFG   (Germany)

Author keywords

Differentiation; E2 protein; HaCaT; HPV 16; Papillomavirus

Indexed keywords

FILAGGRIN; INVOLUCRIN; PROTEIN P53; VIRUS PROTEIN; DNA BINDING PROTEIN; E2 PROTEIN, HUMAN PAPILLOMAVIRUS TYPE 16; INTERMEDIATE FILAMENT PROTEIN; ONCOPROTEIN; PROTEIN PRECURSOR;

APOPTOSIS; ARTICLE; CELL DIFFERENTIATION; CELL GROWTH; CELL STRUCTURE; EPITHELIUM CELL; GENETIC TRANSFECTION; HUMAN PAPILLOMAVIRUS TYPE 16; KERATINOCYTE; NONHUMAN; OPEN READING FRAME; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENESCENCE; BIOSYNTHESIS; CELL AGING; CELL LINE; CYTOLOGY; HUMAN; METABOLISM; PATHOGENICITY; VIROLOGY;

HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS - 16; HUMAN PAPILLOMAVIRUS TYPE 16; PAPILLOMAVIRIDAE;

APOPTOSIS; CELL AGING; CELL DIFFERENTIATION; CELL LINE; DNA-BINDING PROTEINS; HUMAN PAPILLOMAVIRUS 16; HUMANS; INTERMEDIATE FILAMENT PROTEINS; KERATINOCYTES; ONCOGENE PROTEINS, VIRAL; PROTEIN PRECURSORS;

EID: 77952295924     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2010.03.002     Document Type: Article

References (45)

1. Androphy E.J., Lowy D.R., Schiller J.T. Bovine papillomavirus E2 trans-activating gene product binds to specific sites in papillomavirus DNA. Nature 1987, 325:70-73.
2. Bellanger S., Demeret C., Goyat S., Thierry F. Stability of the human papillomavirus type 18 E2 protein is regulated by a proteasome degradation pathway through its amino-terminal transactivation domain. J. Virol. 2001, 75:7244-7251.
3. Boukamp P., Petrussevska R.T., Breitkreutz D., Hornung J., Markham A., Fusenig N.E. Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line. J. Cell Biol. 1988, 106:761-771.
4. Burns J.E., Burn C.L., Hernandez-Ramon E.E., Schmitz C., Lloansi Vila A., Maitland N.J. Forms and functions of papillomavirus E2 proteins. Recent Res. Dev. Biochem. 2003, 4:795-823.
5. Chylicki K., Ehinger M., Svedberg H., Gullberg U. Characterization of the molecular mechanisms for p53-mediated differentiation. Cell Growth Differ. 2000, 11:561-571.
6. Daniel B., Mukherjee G., Seshadri L., Vallikad E., Krishna S. Changes in the physical state and expression of human papillomavirus type 16 in the progression of cervical intraepithelial neoplasia lesions analysed by PCR. J. Gen. Virol. 1995, 76:2589-2593.
7. Demeret C., Garcia-Carranca A., Thierry F. Transcription-independent triggering of the extrinsic pathway of apoptosis by human papillomavirus 18 E2 protein. Oncogene 2003, 22:168-175.
8. Desaintes C., Demeret C., Goyat S., Yaniv M., Thierry F. Expression of the papillomavirus E2 protein in HeLa cells leads to apoptosis. EMBO J. 1997, 16:504-514.
9. Desaintes C., Goyat S., Garbay S., Yaniv M., Thierry F. Papillomavirus E2 induces p53-independent apoptosis in HeLa cells. Oncogene 1999, 18:4538-4545.
10. Dimri C.P., Lee X., Basile G., Acosta M., Roskelley C., Medrano E.E., Linskens M., Rubelj I., Pereira-Smith O., Peacocke M., Campisi J. A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc. Natl. Acad. Sci. U. S. A. 1995, 92:9363-9367.
11. Dostatni N., Thierry F., Yaniv M. A dimer of BPV-1 E2 containing a protease resistant core interacts with its DNA target. EMBO J. 1988, 7:3807-3816.
12. Dowhanick J.J., McBride A.A., Howley P.M. Suppression of cellular proliferation by the papillomavirus E2 protein. J. Virol. 1995, 69:7791-7799.
13. Durst M., Kleinheinz A., Hotz M., Gissmann L. The physical state of human papillomavirus type 16 DNA in benign and malignant genital tumours. J. Gen. Virol. 1985, 66:1515-1522.
14. Gandarillas A. Epidermal differentiation, apoptosis and senescence: common pathways?. Exp. Gerontol. 2000, 35:53-62.
15. Gauthier J.M., Dillner J., Yaniv M. Structural analysis of the human papillomavirus type 16 E2 transactivator with antipeptide antibodies reveals a high mobility region linking the transactivation and the DNA-binding domains. Nucleic Acids Res. 1991, 19:7073-7079.
16. Giri I., Yaniv M. Structural and mutational analysis of E2 trans-activating proteins of papillomaviruses reveals three distinct functional domains. EMBO J. 1988, 7:2823-2829.
17. Goodwin E.C., DiMaio D. Repression of human papillomavirus oncogenes in HeLa cervical carcinoma cells causes the orderly reactivation of dormant tumor suppressor pathways. Proc. Natl. Acad. Sci. U. S. A. 2000, 97:12513-12518.
18. Goodwin E.C., Naeger L.K., Breiding D.E., Androphy E.J., DiMaio D. Transactivation-competent bovine papillomavirus E2 protein is specifically required for efficient repression of human papillomavirus oncogene expression and for acute growth inhibition of cervical carcinoma cell lines. J. Virol. 1998, 72:3925-3934.
19. Goodwin E.C., Yang E., Lee H.-W., DiMaio D., Hwang E.-S. Rapid induction of senescence in human cervical carcinoma cells. Proc. Natl. Acad. Sci. U. S. A. 2000, 97:10978-10983.
20. Hadaschik D., Hinterkeuser K., Oldak M., Pfister H.J., Smola-Hess S. The papillomavirus E2 protein binds to and synergizes with C/EBP factors involved in keratinocyte differentiation. J. Virol. 2003, 77:5253-5265.
21. Henseleit U., Zhang J., Wanner R., Haase I., Kolde G., Rosenbach T. Role of p53 in UVB-induced apoptosis in human HaCaT keratinocytes. J. Invest. Dermatol. 1997, 109:722-727.
22. Hernandez-Ramon E.E., Burns J.E., Zhang W., Walker H.F., Allen S., Antson A.A., Maitland N.J. Dimerization of the human papillomavirus type 16 E2 N terminus results in DNA looping within the upstream regulatory region. J. Virol. 2008, 82:4853-4861.
23. Hwang E.-S., Riese D.J., Settleman J., Nilson L.A., Honig J., Flynn S., DiMaio D. Inhibition of cervical carcinoma cell line proliferation by the introduction of a bovine papillomavirus regulatory gene. J. Virol. 1993, 67:3720-3729.
24. Jia L.Q., Osada M., Ishioka C., Gamo M., Ikawa S., Suzuki T., Shimodaira H., Niitani T., Kudo T., Akiyama M., Kimura N., Matsuo M., Mizusawa H., Tanaka N., Koyama H., Namba M., Kanamaru R., Kuroki T. Screening the p53 status of human cell lines using a yeast functional assay. Mol. Carcinog. 1997, 19:243-253.
25. Johung K., Goodwin E.C., DiMaio D. Human papillomavirus E7 repression in cervical carcinoma cells initiates a transcriptional cascade driven by the retinoblastoma family, resulting in senescence. J. Virol. 2007, 81:2102-2116.
26. Kang H.T., Lee C.J., Seo E.J., Bahn Y.J., Kim H.J., Hwang E.S. Transition to an irreversible state of senescence in HeLa cells arrested by repression of HPV E6 and E7 genes. Mech. Ageing Dev. 2004, 125:31-40.
27. Lehman T.A., Modali R., Boukamp P., Stanek J., Bennett W.P., Welsh J.A., Metcalf R.A., Stampfer M.R., Fusenig N., Rogan E.M., Harris C.C. p53 mutations in human immortalized epithelial cell lines. Carcinogenesis 1993, 14:833-839.
28. Magal S.S., Jackman A., Pei X.F., Schlegel R., Sherman L. Induction of apoptosis in human keratinocytes containing mutated p53 alleles and its inhibition by both the E6 and E7 oncoproteins. Int. J. Cancer 1998, 75:96-104.
29. Maitland N.J., Conway S., Wilkinson N.S., Ramsdale J., Morris J.R., Sanders C.M., Burns J.E., Stern P.L., Wells M. Expression patterns of the human papillomavirus type 16 transcription factor E2 in low- and high-grade cervical intraepithelial neoplasia. J. Pathol. 1998, 186:275-280.
30. Moon M.S., Lee C.J., Um S.J., Park J.S., Yang J.M., Hwang E.S. Effect of BPV1 E2-mediated inhibition of E6/E7 expression in HPV16-positive cervical carcinoma cells. Gynecol. Oncol. 2001, 80:168-175.
31. Müller A., Ritzkowsky A., Steger G. Cooperative activation of human papillomavirus type 8 gene expression by the E2 protein and the cellular coactivator p300. J. Virol. 2002, 76:11042-11053.
32. Naeger L.K., Goodwin E.C., Hwang E.S., DeFilippis R.A., Zhang H., DiMaio D. Bovine papillomavirus E2 protein activates a complex growth- inhibitory program in p53-negative HT-3 cervical carcinoma cells that includes repression of cyclin A and cdc25A phosphatase genes and accumulation of hypophosphorylated retinoblastoma protein. Cell Growth Differ. 1999, 10:413-422.
33. Oldak M., Smola H., Aumailley M., Rivero F., Pfister H., Smola-Hess S. The human papillomavirus type 8 E2 protein suppresses β4-integrin expression in primary human keratinocytes. J. Virol. 2004, 78:10738-10746.
34. Parish J.L., Kowalczyk A., Chen H.T., Roeder G.E., Sessions R., Buckle M., Gaston K. E2 proteins from high- and low-risk human papillomavirus types differ in their ability to bind p53 and induce apoptotic cell death. J. Virol. 2006, 80:4580-4590.
35. Piirsoo M., Ustav E., Mandel T., Stenlund A., Ustav M. Cis and trans requirements for stable episomal maintenance of the BPV-1 replicator. EMBO J. 1996, 15:1-11.
36. Sanchez-Perez A.-M., Soriano S., Clarke A.R., Gaston K. Disruption of the human papillomavirus type 16 E2 gene protects cervical carcinoma cells from E2F-induced apoptosis. J. Gen. Virol. 1997, 78:3009-3018.
37. Schmitz, C., 2000. Transient and stable expression of the human papillomavirus type 16 (HPV-16) early protein 2 (E2) in human keratinocytes. DPhil Thesis, University of York, UK.
38. Stevenson M., Hudson L.C., Burns J.E., Stewart R.L., Wells M., Maitland N.J. Inverse relationship between the expression of the human papillomavirus type 16 transcription factor E2 and virus DNA copy number during the progression of cervical intraepithelial neoplasia. J. Gen. Virol. 2000, 81:1825-1832.
39. Thierry F., Demeret C. Direct activation of caspase 8 by the proapoptotic E2 protein of HPV18 independent of adaptor proteins. Cell Death Differ. 2008, 15:1356-1363.
40. Ustav M., Stenlund A. Transient replication of BPV-1 requires two viral polypeptides encoded by the E1 and E2 open reading frames. EMBO J. 1991, 10:449-457.
41. Waller A.S., Sharrard R.M., Berthon P., Maitland N.J. Androgen receptor localisation and turnover in human prostate epithelium treated with the anitandrogen, Casodex. J. Mol. Endocrinol. 2000, 24:339-351.
42. Webster K., Parish J., Pandya M., Stern P.L., Clarke A.R., Gaston K. The human papillomavirus (HPV) 16 E2 protein induces apoptosis in the absence of other HPV proteins and via a p53-dependent pathway. J. Biol. Chem. 2000, 275:87-94.
43. CIP-dependent pathways. EMBO J. 2000, 19:5762-5771.
44. Wells S.I., Aronow B.J., Wise T.M., Williams S.S., Couget J.A., Howley P.M. Transcriptome signature of irreversible senescence in human papillomavirus-positive cervical cancer cells. Proc. Natl. Acad. Sci. U. S. A. 2003, 100:7093-7098.
45. zur Hausen H., De Villiers E.-M. Human papillomaviruses. Annu. Rev. Microbiol. 1994, 48:427-447.